Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Landos Biopharma, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −4 vs. Q2 2022
- Shares held
- 21.6M
- −861.2K (−3.8%) vs. Q2 2022
- Total value
- $14.0M
- −$2.31M (−14.1%) vs. Q2 2022
- New holders
- 5
- 5 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 16 | $34.9M |
| Q4 2023 | 10 | $5.58M |
| Q3 2023 | 11 | $5.93M |
| Q2 2023 | 8 | $6.27M |
| Q1 2023 | 20 | $4.63M |
| Q4 2022 | 23 | $7.87M |
| Q3 2022 | 31 | $14.0M |
| Q2 2022 | 35 | $16.4M |
| Q1 2022 | 45 | $35.3M |
| Q4 2021 | 40 | $119.8M |
| Q3 2021 | 35 | $331.1M |
| Q2 2021 | 33 | $261.4M |
| Q1 2021 | 47 | $218.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 104 | $0 | 0.00% | −3,939−97.4% | Reduced |
| Citigroup Inc | 495 | $0 | 0.00% | −246−33.2% | Reduced |
| Acadian Asset Management LLC | 1,344 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 685 | $0 | 0.00% | +342+99.7% | Added |
| China Universal Asset Management Co., Ltd. | 377 | $0 | 0.00% | +377 | New |
| BNP Paribas Arbitrage, SA | 1,122 | $729 | 0.00% | +1,122 | New |
| JPMorgan Chase & Co | 2,242 | $1.00K | 0.00% | +516+29.9% | Added |
| FMR LLC | 2,000 | $1.00K | 0.00% | +44+2.2% | Added |
| Morgan Stanley | 8,653 | $5.00K | 0.00% | −996−10.3% | Reduced |
| Tower Research Capital LLC (TRC) | 10,016 | $7.00K | 0.00% | +356+3.7% | Added |
| Stratos Wealth Partners, LTD. | 10,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 12,219 | $8.00K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 13,092 | $9.00K | 0.00% | −29,708−69.4% | Reduced |
| Man Group plc | 14,387 | $9.00K | 0.00% | +14,387 | New |
| Balyasny Asset Management LLC | 15,687 | $10.0K | 0.00% | +15,687 | New |
| Bank of America Corp | 16,482 | $11.0K | 0.00% | −23,798−59.1% | Reduced |
| Two Sigma Investments, LP | 19,420 | $13.0K | 0.00% | −27,040−58.2% | Reduced |
| Two Sigma Advisers, LP | 19,800 | $13.0K | 0.00% | −14,100−41.6% | Reduced |
| State Street Corp | 25,200 | $16.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 41,760 | $27.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 77,554 | $50.0K | 0.00% | 00.0% | Unchanged |
| Green Square Capital Advisors LLC | 84,500 | $55.0K | 0.01% | +84,500 | New |
| Botty Investors LLC | 127,262 | $83.0K | 0.03% | 00.0% | Unchanged |
| Macquarie Group Ltd | 147,182 | $96.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 149,000 | $97.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 166,608 | $108.0K | 0.00% | +39,053+30.6% | Added |
| Renaissance Technologies LLC | 258,701 | $168.0K | 0.00% | −130,031−33.5% | Reduced |
| BlackRock Inc. | 296,885 | $193.0K | 0.00% | −17,856−5.7% | Reduced |
| OUP Management Co., LLC | 1,237,667 | $804.0K | 1.25% | −375,097−23.3% | Reduced |
| RTW Investments, LP | 3,975,722 | $2.58M | 0.06% | −300,000−7.0% | Reduced |
| Perceptive Advisors LLC | 14,869,915 | $9.66M | 0.28% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −22,900−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,119−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,957−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,529−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,350−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −5,286−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,243−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −418−100.0% | Sold out |